Advancing Cancer Diagnostics in Nigeria: A Collaborative Vision

Dr. Modupe Elebute-Odunsi, MBBS, MD, FRCP, FRCPath, Co-Founder and CEO of Marcelle Ruth Cancer Centre & Specialist Hospital, had the pleasure of being hosted by Dr. Kate Isa, CEO of Katchey Company Limited, and the entire team at Katchey Laboratory.

Dr. Kate Isa expressed her happiness in hosting Dr. Modupe Elebute-Odunsi, a leading voice in oncology and precision medicine. Their discussions during the visit sparked important conversations about the future of cancer diagnostics in Nigeria and how collaboration can drive meaningful change.

Dr. Kate Isa emphasized her deep commitment to building a cancer diagnostics ecosystem that truly serves Nigerians—one where patients no longer have to wait weeks for test results or send critical samples abroad. At Katchey Laboratories, the goal is to ensure that cancer researchers, oncologists, and healthcare professionals have access to advanced molecular and analytical tools within the country.

She stated that Africa’s fight against cancer cannot rely solely on external solutions. There is a pressing need for robust, localized systems that deliver reliable, timely, and accessible diagnostics tailored to the continent’s unique needs. This vision drives her daily, and she looks forward to collaborating with experts like Dr. Modupe Elebute-Odunsi to make it a reality.

In response, Dr. Modupe Elebute-Odunsi expressed her admiration for the extensive range of analytical and clinical tests conducted at Katchey Laboratories. She highlighted the use of state-of-the-art equipment, adherence to international standards, and the high level of expertise within the team.

She also shared her excitement about the potential collaboration in histopathology, molecular, and genetic testing, which would further advance the goal of providing world-class care for Nigerian patients—right here in Nigeria.